What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Disease
Immunology, Immunodeficiency, Transplantation, Internal medicine and Hematopoietic stem cell transplantation are his primary areas of study.
His work is dedicated to discovering how Immunology, Virology are connected with Gene and other disciplines.
His Immunodeficiency research integrates issues from P110δ, Mutation, T cell, Autoimmune disease and Allergy.
Andrew J. Cant combines subjects such as Survival analysis, Pediatrics, Severe combined immunodeficiency and Chronic granulomatous disease with his study of Transplantation.
In his study, Busulfan and Transplantation Conditioning is strongly linked to Gastroenterology, which falls under the umbrella field of Internal medicine.
His Hematopoietic stem cell transplantation research is multidisciplinary, incorporating perspectives in Survival rate, Hematology, DOCK8 Deficiency and Progressive multifocal leukoencephalopathy.
His most cited work include:
- Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I (509 citations)
- Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99 (470 citations)
- IRF8 mutations and human dendritic-cell immunodeficiency. (447 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Immunology, Transplantation, Primary immunodeficiency, Internal medicine and Immunodeficiency.
The concepts of his Immunology study are interwoven with issues in Hematopoietic stem cell transplantation and Severe combined immunodeficiency.
His studies deal with areas such as Stem cell and Chronic granulomatous disease as well as Transplantation.
The various areas that Andrew J. Cant examines in his Primary immunodeficiency study include Intensive care medicine, Pediatrics and Virology.
His research integrates issues of Gastroenterology, Transplantation Conditioning and Oncology in his study of Internal medicine.
His studies in Immunodeficiency integrate themes in fields like Mutation, Cancer research and Pathology.
He most often published in these fields:
- Immunology (57.66%)
- Transplantation (27.58%)
- Primary immunodeficiency (25.07%)
What were the highlights of his more recent work (between 2015-2021)?
- Immunology (57.66%)
- Hematopoietic stem cell transplantation (20.61%)
- Primary immunodeficiency (25.07%)
In recent papers he was focusing on the following fields of study:
Andrew J. Cant focuses on Immunology, Hematopoietic stem cell transplantation, Primary immunodeficiency, Transplantation and Immunodeficiency.
Andrew J. Cant has included themes like Exome sequencing and Stem cell in his Immunology study.
The study incorporates disciplines such as Total body irradiation, Severe combined immunodeficiency and Lymphocyte in addition to Hematopoietic stem cell transplantation.
Internal medicine and Surgery are inextricably linked to his Transplantation research.
His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Oncology.
His Immunodeficiency research includes elements of Phenotype, Cancer research and Chemotaxis.
Between 2015 and 2021, his most popular works were:
- Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study. (182 citations)
- Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4–insufficient subjects (132 citations)
- The European Society for Immunodeficiencies (ESID) Registry Working Definitions for the Clinical Diagnosis of Inborn Errors of Immunity (123 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Disease
Andrew J. Cant mainly focuses on Immunology, Transplantation, Immunodeficiency, Primary immunodeficiency and Hematopoietic stem cell transplantation.
His Immunology study combines topics in areas such as Biallelic Mutation and IRF8.
His Transplantation study deals with the bigger picture of Surgery.
Andrew J. Cant has researched Immunodeficiency in several fields, including Phenotype, Chemotaxis, Cell adhesion, Nonsense mutation and Intercellular Adhesion Molecule-1.
His work carried out in the field of Primary immunodeficiency brings together such families of science as Exome sequencing, Autoimmune disease, Prednisolone, Tacrolimus and Rituximab.
His Hematopoietic stem cell transplantation study is associated with Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
